The US FDA inspection for Silvassa facility of Ipca Labs conducted during 19-23 August 2019. It is the formulation facility of Ipca Labs.
The firms receive three US FDA observations in Form 483.
The complete response to the received observations will be shared by the company officials within the fixed time period.
Copyright © 2021 Institute of Good Manufacturing Practices India ( IGMPI® All Rights Reserved. Trademarks are the property of the owner )